La Vita Compounding Pharmacy, LLC

CLOSEOUT LETTER La Vita Compounding Pharmacy, LLC MARCS-CMS 575286 — September 03, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Electronic Mail Recipient: Recipient Name Christine A. Givant Recipient Title Pharmacist in Charge La Vita Compounding Pharmacy, LLC 3978 Sorrento Valley Boulevard Suite 300 San Diego , CA 92121-1436 United States Issuing Office: Division of Pharmaceutical Quality Operations IV United States Dear Ms. Givant: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (CMS No. 575286) dated February 28, 2019. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ CDR Steven E. Porter, Jr. Director, Division of Pharmaceutical Quality Operations IV Content current as of: 09/15/2020